These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 10329091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Carvedilol in ischemic heart failure. Hibernating myocardium resuscitated].
    MMW Fortschr Med; 2003 Feb 20; 145(8):57. PubMed ID: 12661451
    [No Abstract] [Full Text] [Related]

  • 3. Carvedilol: use in chronic heart failure.
    Doughty RN, White HD.
    Expert Rev Cardiovasc Ther; 2007 Jan 20; 5(1):21-31. PubMed ID: 17187454
    [Abstract] [Full Text] [Related]

  • 4. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS, Senior R, Soman P, van der Does R, Lahiri A.
    Am Heart J; 2001 Oct 20; 142(4):704-13. PubMed ID: 11579363
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dismantling mandates in the treatment of heart failure.
    Leier CV.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1831-3. PubMed ID: 15519015
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?
    Remme WJ.
    Heart Fail Clin; 2005 Apr 02; 1(1):67-75. PubMed ID: 17386835
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE.
    Am J Cardiol; 2004 May 06; 93(9A):43B-8B. PubMed ID: 15144937
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results.
    Doughty RN, Sharpe N.
    Annu Rev Med; 1997 May 06; 48():103-14. PubMed ID: 9046949
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S, MUCHA Investigators.
    Am Heart J; 2004 Feb 06; 147(2):324-30. PubMed ID: 14760332
    [Abstract] [Full Text] [Related]

  • 16. Using carvedilol to treat heart failure.
    Taccetta-Chapnick M.
    Crit Care Nurse; 2002 Apr 06; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Myocardial dysfunction: hibernation and remodelling.
    Köszegi Z, Balogh E.
    Lancet; 2003 Oct 25; 362(9393):1416-7; author reply 1417. PubMed ID: 14585649
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.